Get started
PHARMALA BIOTECH HOLDINGS INC.PHARMALA BIOTECH HOLDINGS INC.PHARMALA BIOTECH HOLDINGS INC.

PHARMALA BIOTECH HOLDINGS INC.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

MDMA chart


Full chart

Key stats


Market capitalization
‪22.07 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.010 CAD
Net income (FY)
‪−779.81 K‬ CAD
Revenue (FY)
‪532.00 K‬ CAD
Shares float
‪88.52 M‬
Beta (1Y)
3.09

About PHARMALA BIOTECH HOLDINGS INC.


Sector
Health Technology
CEO
Nicholas Kadysh
Headquarters
Toronto
Website
pharmala.ca
FIGI
BBG014H7BPY1
PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MDMA news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MDMA is 0.240 CAD — it has increased by 2.17% in the past 24 hours. Watch PHARMALA BIOTECH HOLDINGS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange PHARMALA BIOTECH HOLDINGS INC. stocks are traded under the ticker MDMA.
MDMA stock has fallen by −21.67% compared to the previous week, the month change is a −25.40% fall, over the last year PHARMALA BIOTECH HOLDINGS INC. has showed a 118.18% increase.
MDMA reached its all-time high on May 2, 2023 with the price of 0.540 CAD, and its all-time low was 0.020 CAD and was reached on May 11, 2022. View more price dynamics on MDMA chart.
See other stocks reaching their highest and lowest prices.
MDMA stock is 9.09% volatile and has beta coefficient of 3.09. Track PHARMALA BIOTECH HOLDINGS INC. stock price on the chart and check out the list of the most volatile stocks — is PHARMALA BIOTECH HOLDINGS INC. there?
Yes, you can track PHARMALA BIOTECH HOLDINGS INC. financials in yearly and quarterly reports right on TradingView.
MDMA net income for the last quarter is ‪−413.15 K‬ CAD, while the quarter before that showed ‪−222.57 K‬ CAD of net income which accounts for −85.63% change. Track more PHARMALA BIOTECH HOLDINGS INC. financial stats to get the full picture.
No, MDMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMALA BIOTECH HOLDINGS INC. EBITDA is ‪−496.09 K‬ CAD, and current EBITDA margin is −136.66%. See more stats in PHARMALA BIOTECH HOLDINGS INC. financial statements.
Like other stocks, MDMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMALA BIOTECH HOLDINGS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMALA BIOTECH HOLDINGS INC. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMALA BIOTECH HOLDINGS INC. stock shows the strong buy signal. See more of PHARMALA BIOTECH HOLDINGS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.